References
[1] Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic
literatrure review of the clinical and epidemiology burden of acute lymphoblastic
leukaemia (ALL). Europ J Cancer Care 2005;14:53-62
[2] Gessain A, Barin F, Vernant JC et al.. Antibodies to human T-lymphotropic virus
type-1 in patients with tropical spastic paraparesis. Lancet. 1985; 2:407-410
[3] Kashiwagi K, Furusyo N, Nakashima H, Kubo N, et al. A decrease in mother-to-
child transmission of human T lymphotropic virus type 1 (HTLV-1) in Okinawa, Japan.
Am J Trop Hyg 2004;70(2):158-163
[4] Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus
type I-induced diseas: pathways to cancer and neurodegeneration. Virology 2003;
308(1):1-12
[5] Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, Wigdahl B. Human T Cell
Leukemia Virus Type 1 and Neurologic Disease: Events in Bone Marrow, Peripheral
Blood, and Central Nervous System during normal Immune Surveillance and
Neuroinflammation. J Cell Physiol. 2002;190:133-159
[6] Feuer G., Fraser J, Zack J, Lee F, Feuer R, Chen I. Human T-cell leukemai virus
infection of human hematopoietic progenitor cells: maintenance during differentiation
in vitro and in vivo. J Virol. 1996;70:4038-4044
[7] Levin MC, Krichavsky M, Fox RJ, Lehky T, Jacobson S, Fox C, Kleghorn F,
White J, Young N, Edwards RJ, Jack NE, Bartholomew C. Extensive latent retroviral
infection in bone marrow of patients with HTLV-1-associated neurologic disease.
Blood 1997;89:346-348
[8] Nagafuji K, Harada M, Teshima T, Eto T, Takamatsu Y, Okamura T, Murakawa M,
Akashi K, Niho Y. Hematopoetic Progenitor Cells from patients with adult T-cell
leukemia-lymphoma are not infected with human T-cell leukemia virus Type I. Blood
1993;82:2823-2828
[9] Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global
epidemiology of HTLV-1 infection and associated diseases. Oncogene
2005;24:6058-6068
[10] Catalan-Soares B, Carneiro-Proietti F, Proietti F.A. Heterogeneous geographic
distribution of human T-cell lymphotropic viruses 1 and 2 (HTLV1/2): serological
screening prevalence rates in blood donors from large ruban areas in Brazil. Cad.
Saúde Pública 2005;21(3):926-931